[Clinical testing of a bronchospasmolytic drug in retard form].
D001535:Benactyzine / Q000627:therapeutic use; D001982:Bronchial Diseases / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D004338:Drug Combinations; D006801:Humans; D010634:Phenobarbital / Q000627:therapeutic use; D011437:Propylamines / Q000627:therapeutic use; D013805:Theobromine / Q000031:analogs & derivatives / Q000627:therapeutic use
D001993:Bronchodilator Agents; D003692:Delayed-Action Preparations; D004338:Drug Combinations; D011437:Propylamines; D001535:Benactyzine; D013805:Theobromine; D010634:Phenobarbital
Zur klinischen Prüfung eines Broncho-spasmolytikums in Retard-Form